Categories: News

Study Showing Pathway to Significant Greenhouse Emissions Reductions In Medical Device Supply Chain to be Released July 30, 2024, 8:45 AM ET

Greenhouse Emissions and Environmental Footprint Reduced Significantly By Innovative Medical Device

STAMFORD, Conn., July 29, 2024 /PRNewswire/ — 

WHAT: A new peer reviewed study to be released July 30, 2024, comparing the environmental footprint of an innovative prefilled injection device to widely used traditional glass syringe options. This groundbreaking study shows that greenhouse gas emissions can be reduced significantly by soon to be available blow-fill-seal (BFS) manufactured prefilled injectors.

WHO: The study’s authors are Robert Litan, PhD, former Director of Economic Studies at The Brookings Institution and Matthew Eckelman, PhD, Adjunct Associate Professor at the Yale School of Public Health, with expertise in emissions modeling. The authors were supported by engineers and scientists from Kymanox, a global professional services company exclusively serving life sciences.

WHY: The year-long study finds a substantial difference favoring the Prefilled Injector developed by ApiJect Systems across all categories of resource use and environmental impact. In quantifying an environmental footprint, the study identified and measured each step in the production and distribution processes of the different types of injection devices.

Compared to the Prefilled ApiJect Injector result of 38 g CO2-eq per dose:

  • Single-Dose Glass Vial impacts are approximately 125% higher per dose;
  • Luer-type Prefilled Syringes are approximately 100% higher per dose;
  • Multi-Dose Vial and Staked-type Prefilled Syringes are 65-75% higher per dose.

Measuring water use for manufacturing, cleaning and sterilization, the study also found that a typical single-dose glass vial requires over 100 times more water than the Prefilled ApiJect Injector.

WHEN: Press Release and Report available July 30, 2024 at 8:45 am ET. For live link, visit apiject.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/study-showing-pathway-to-significant-greenhouse-emissions-reductions-in-medical-device-supply-chain-to-be-released-july-30-2024-845-am-et-302208664.html

SOURCE ApiJect Systems Corp.

Staff

Recent Posts

HeartBeam to Attend JP Morgan 2025 Annual Healthcare Conference

HeartBeam system was recently cleared by US Food and Drug Administration (FDA) for comprehensive arrhythmia…

9 minutes ago

Glaukos Submits New Drug Application to U.S. FDA for Epioxa™

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused…

10 minutes ago

The National Children’s Cancer Society Awarded $1,000 Grant From Kars4Kids

This generous grant will directly benefit the NCCS's Beyond the Cure Ambassador Scholarship Program, which…

14 minutes ago

Honeycomb Clinic Positions for Public Offering

Medical Co-working space challenges broken healthcare system. HOUSTON, TEXAS / ACCESSWIRE / December 23, 2024…

14 minutes ago

Ensysce Biosciences Regains Full Compliance with Nasdaq

SAN DIEGO, CALIFORNIA / ACCESSWIRE / December 23, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce"…

14 minutes ago

Telomir Pharmaceuticals Confirms Copper Binding Capabilities of Telomir-1 and Expands Pipeline Into Wilson’s Disease

MIAMI, FL / ACCESSWIRE / December 23, 2024 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO), or the…

14 minutes ago